Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Acute Respiratory Syndrome (SARS-CoV-2 Virus)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05643781
What this trial is testing

Tuberculosis as a Risk Factor for a Worse Outcome Post-Sars-CoV-2 Infection

Who this might be right for
COVID-19TuberculosisPost-acute COVID-19 Syndrome
The Aurum Institute NPC 157
Testing effectiveness (Phase 2)Study completedNCT04707664
What this trial is testing

Sargramostim Use in COVID-19 to Recover Patient Health

Who this might be right for
Covid19SARS-CoV Infection
Partner Therapeutics, Inc. 600
Testing effectiveness (Phase 2)Study completedNCT04576728
What this trial is testing

Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19

Who this might be right for
Covid19
Biotest 166
Not applicableStudy completedNCT04760990
What this trial is testing

Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort.

Who this might be right for
Multiple SclerosisCOVID-19 (Severe Coronavirus Disease 2019)
University Hospital, Basel, Switzerland 1,181
Not applicableStudy completedNCT04665960
What this trial is testing

Infection Control for Severe Acute Respiratory Syndrome Coronavirus 2

Who this might be right for
Covid19SARS-CoV InfectionSARS Pneumonia+2 more
NMC Specialty Hospital 35
Not applicableEnded earlyNCT04369989
What this trial is testing

Observational Study of COVID-19 Treatment Efficacy

Who this might be right for
CoronavirusCoronavirus InfectionCorona Virus Infection+7 more
OSF Healthcare System 250
Not applicableUnknownNCT04345315
What this trial is testing

Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent.

Who this might be right for
COVID-19SARS-CoV-2
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 500
Early research (Phase 1)Study completedNCT05656508
What this trial is testing

ARVAC - A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine

Who this might be right for
COVID-19 Vaccine
Laboratorio Pablo Cassara S.R.L. 80
Not applicableUnknownNCT04935450
What this trial is testing

Pulmonary Inflammation in COVID-19 ARDS

Who this might be right for
ARDS Due to Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2COVID-19 Acute Respiratory Distress Syndrome
Hospital Universitario Ramon y Cajal 25
Early research (Phase 1)Study completedNCT05870839
What this trial is testing

Study of VXCO-100, a SARS-CoV Candidate Vaccine in Healthy Adults in the United States

Who this might be right for
SARS-CoVSARS-CoV-2
Vaccine Company, Inc. 121
Large-scale testing (Phase 3)UnknownNCT04641481
What this trial is testing

An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Who this might be right for
Covid19SARS-CoV Infection
Bharat Biotech International Limited 25,800
Early research (Phase 1)Study completedNCT04646044
What this trial is testing

A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19

Who this might be right for
Covid-19Coronavirus Disease 2019
Nektar Therapeutics 30
Not applicableStudy completedNCT04745611
What this trial is testing

Neurological and Neuropsychological Sequelae of COVID-19 Infection

Who this might be right for
COVID-19 Infection
Maastricht University 329
Large-scale testing (Phase 3)Ended earlyNCT04516811
What this trial is testing

Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19

Who this might be right for
COVID-19SARS-CoV-2 InfectionSevere Acute Respiratory Syndrome Coronavirus 2
South African National Blood Service 102
Early research (Phase 1)Ended earlyNCT04652765
What this trial is testing

Camostat With Bicalutamide for COVID-19

Who this might be right for
Covid19SARS-CoV InfectionCoronavirus Infection
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 6
Large-scale testing (Phase 3)Study completedNCT04380519
What this trial is testing

Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19)

Who this might be right for
COVID-19
R-Pharm International, LLC 372
Early research (Phase 1)Study completedNCT05844202
What this trial is testing

Safety, Tolerability and Immunogenicity of Alveavax-v1.2, a BA.2/Omicron-optimized, DNA Vaccine for COVID-19 Prevention

Who this might be right for
Sars-CoV-2 Infection
Alvea Holdings, LLC 130
Not applicableStudy completedNCT05104411
What this trial is testing

Rehabilitation in Severely Ill Inpatients With COVID-19

Who this might be right for
COVID-19
Seoul National University Bundang Hospital 37
Post-approval studies (Phase 4)UnknownNCT04639375
What this trial is testing

Polio Vaccine (IPV) for SARS-CoV-2 and Prevention of Coronavirus Disease (COVID-19)

Who this might be right for
SARS-CoV-2
E-MO Biology Inc 300
Testing effectiveness (Phase 2)Study completedNCT04761822
What this trial is testing

COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations

Who this might be right for
SARS-CoV InfectionCOVID-19Allergic Reaction+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 746
Next Page